web analytics

AI Pipeline For Predicting Oral Cancer Progression

Published:
Lead Inventor: Alexander Pearson

SUMMARY

An AI-driven system analyzes histopathology images of oral lesions using deep learning, self-supervised learning, and attention methods to predict cancer progression risk with explainable and uncertainty-quantified outputs that inform treatment decisions.

The Unmet Need: Automated and accurate malignancy prediction tools

  • The field of digital pathology and cancer diagnostics is evolving to address the growing need for improved prognostic tools that can identify disease progression earlier. With chronic conditions like oral cancer, early detection of malignant transformation from premalignant lesions is critical for effective intervention. However, traditional approaches, which largely rely on visual inspection and biopsy, have proven inadequate for consistently predicting which lesions may develop into full-blown cancer. This gap in effective early diagnostic techniques underscores an urgent clinical need for more reliable and predictive methods.
  • Existing diagnostic methodologies are hampered by several issues. Visual and tactile examinations are inherently subjective and prone to interpretative variability, while biopsy procedures can be invasive and may not offer definitive prognostic insights. These limitations often result in either overtreatment or missed opportunities for early interventions, creating a scenario where significant clinical uncertainties persist. Such challenges highlight the persistent demand for enhanced diagnostic strategies that can more accurately assess risk and guide timely, targeted treatment decisions.

The Proposed Solution: An AI-driven pipeline for predicting the progression of oral premalignant lesions to carcinoma using histopathology images

  • The faculty inventor developed an AI pipeline employing deep learning to analyze histopathology images from oral tissues, enabling precise risk assessment of premalignant lesions turning into cancer. It utilizes self-supervised learning to extract robust features from unlabeled data and incorporates attention-based multiple instance learning to effectively process whole-slide images without extensive manual annotation. The approach includes specialized epithelium segmentation and optimized feature extraction with stain normalization and augmentation, ensuring that the analysis focuses on the most clinically relevant tissue regions while handling variations in slide preparation.
  • What distinguishes this system is its comprehensive framework that bridges computational techniques with clinical applicability. By integrating uncertainty quantification, the method provides clinicians with clear confidence levels for its predictions, thus enhancing treatment decision-making. Additionally, the use of explainable AI allows for transparent insight into the latent features driving its risk stratification, fostering trust and interpretability. These advancements collectively address the limitations of traditional diagnostic methods, reducing the risks of overtreatment and undertreatment, and offering a more informed, data-driven approach to patient management.

ADVANTAGES

ADVANTAGES

  • Enhances risk stratification by accurately predicting which oral premalignant lesions are likely to progress to cancer

  • Reduces reliance on labor-intensive, subjective manual annotations through attention-based multiple instance learning

  • Improves model robustness and generalizability with self-supervised learning and optimized feature extraction/normalization

  • Provides uncertainty quantification and explainable AI insights to support informed clinical decision-making

  • Facilitates personalized treatment planning by enabling appropriate escalation or de-escalation of interventions

APPLICATIONS

  • Oral cancer risk stratification

  • Histopathology slide analysis

  • Clinical decision support

  • Automated epithelium segmentation